Related Experiment Video
Updated: May 9, 2025
10:19
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
1.2K
Recent development in bispecific antibody immunotherapy for hematological malignancies
Lijie Han1, Ke Wang2, Zhongxing Jiang1
1Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Critical Reviews in Oncology/Hematology
|May 4, 2025
Summary
Bispecific antibodies (BsAbs) offer a novel approach to cancer immunotherapy by targeting two antigens simultaneously. These advanced therapies show promise in treating hematological malignancies, improving precision and efficacy.
Area of Science:
- Oncology
- Immunotherapy
- Biotechnology
Background:
- Monoclonal antibodies (mAbs) have advanced cancer treatment but face challenges like resistance.
- Novel strategies are needed to overcome tumor progression and treatment resistance.
Purpose of the Study:
- To review structural and functional innovations in bispecific antibodies (BsAbs).
- To explore the potential of BsAbs in hematological malignancy immunotherapy.
- To discuss challenges and future directions for BsAb therapy.
Main Methods:
- Review of recent advancements in BsAb design and clinical applications.
- Analysis of BsAb efficacy in treating hematological malignancies.
- Exploration of combination therapies involving BsAbs.
Main Results:
- BsAbs demonstrate improved therapeutic precision, efficacy, and safety compared to mAbs.
- Leading BsAbs show promising results in clinical trials for leukemia and lymphoma.
- BsAbs can redirect cytotoxic effector cells to tumor sites.
Conclusions:
- BsAbs represent a promising next-generation therapy for hematological malignancies.
- Combination therapies with BsAbs may overcome resistance and improve outcomes.
- Ongoing research aims to enhance BsAb efficacy in relapsed or refractory diseases, including AML.
Related Concept Videos
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
01:31Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:22Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
01:24B Cell Activation and Differentiation
1.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.2K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K